Decentralized Trials in a Post-Pandemic World

Technology and DCT have enormous potential. But discernment is key; we must learn from what worked and didn't, integrating technologies that enhance patient-centricity without overloading sites.

Joined by Nael Abdelsamad and his extensive experience, we’ll navigate the shift towards decentralized trials to leveraging AI and machine learning, uncovering the keys to sustained innovation and patient-centricity. Nael has dedicated his career to clinical operations and trial management, working with prestigious medical centers and renowned organizations like CVS Health. Discover how technology integration, big data utilization, and workforce development are shaping the future landscape of clinical trials.

Join us as we discuss:

• Challenges and opportunities in the clinical trial industry, particularly in the wake of COVID-19
• The decentralized clinical trials (DCT) model
• The thoughtful incorporation of AI and machine learning
• Connectivity between all platforms and integration capabilities
• The importance of reducing tech overload and enhancing workforce development.